RUBIN JONATHAN (SVP, Chief Medical Officer) reported 3 transactions at SUPERNUS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/5/2025ACC: 0001628280-25-010437
Officer· SVP, Chief Medical Officer
Since Jan 2021
-1.47K
Net shares
Net seller
$48.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.47K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−314.00
Price / share
$33.05
Trade value
$10.38K
% of position
2.8%
3/5/2025
11.10K→10.79K
Common Stock
Direct
Shares
−577.00
Price / share
$33.05
Trade value
$19.07K
% of position
5.3%
3/5/2025
10.79K→10.21K
Common Stock
Direct
Shares
−577.00
Price / share
$33.05
Trade value
$19.07K
% of position
5.7%
3/5/2025
10.21K→9.63K
Total
Net shares
−1.47K
Net value
-$48.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2025 | F · Tax Withholding | −314.00 | $33.05 | $10.38K | 2.8% | 11.10K | 10.79K |
| Common Stock Direct | 3/5/2025 | F · Tax Withholding | −577.00 | $33.05 | $19.07K | 5.3% | 10.79K | 10.21K |
| Common Stock Direct | 3/5/2025 | F · Tax Withholding | −577.00 | $33.05 | $19.07K | 5.7% | 10.21K | 9.63K |
| Total | −1.47K | -$48.52K | ||||||
Derivative Transactions0
No derivative transactions reported